World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
105
Citations
48539
World Ranking
6701
National Ranking
3537

Robert E. Gerszten publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Robert E. Gerszten sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 511 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Robert E. Gerszten D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Robert E. Gerszten sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 105 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Robert E. Gerszten is affiliated with Beth Israel Deaconess Medical Center in the United States, contributing extensively to research in medicine and biochemistry, genetics, and molecular biology.

Their research spans multiple subfields, including molecular biology, physiology, genetics, cardiology and cardiovascular medicine, and epidemiology. Their work focuses on areas such as metabolomics and mass spectrometry studies, adipose tissue and metabolism, genetic associations and epidemiology, diet and metabolism studies, bioinformatics and genomic networks, cardiovascular and exercise physiology, and nutritional studies and diet.

Robert E. Gerszten has published frequently in a range of scientific venues. The most common journals include:

  • Circulation
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Diabetes
  • Medicine & Science in Sports & Exercise
  • Circulation Research

Their recent papers include the following:

  • Exerkines in health, resilience and disease, 2022, Nature Reviews Endocrinology
  • Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease, 2020, JAMA
  • Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions, 2021, Cell Reports Medicine
  • Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet, gut microbiome and circulating metabolites in cohort studies, 2021, Gut
  • Metabolomics and Proteomics in Type 2 Diabetes, 2020, Circulation Research

Frequent collaborators in Robert E. Gerszten's research include:

  • Clary B. Clish
  • Jeremy Robbins
  • Stephen S. Rich
  • Jerome I. Rotter
  • Usman A. Tahir

Robert E. Gerszten has been recognized as a member of the Association of American Physicians. Their publication record shows a significant focus on integrating molecular biology techniques with clinical and epidemiological approaches to address complex health conditions, including cardiovascular diseases and metabolic disorders.

Best Publications

  • The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

    Heather R. Christofk;Matthew G. Vander Heiden;Marian H. Harris;Arvind Ramanathan

  • Metabolite profiles and the risk of developing diabetes

    Thomas J Wang;Martin G Larson;Martin G Larson;Ramachandran S Vasan;Ramachandran S Vasan;Susan Cheng;Susan Cheng;Susan Cheng

  • Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.

    Daniel Taliun;Daniel N. Harris;Michael D. Kessler;Jedidiah Carlson;Jedidiah Carlson

  • MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions.

    Robert E. Gerszten;Eduardo A. Garcia-Zepeda;Yaw-Chyn Lim;Yaw-Chyn Lim;Masayuki Yoshida

  • MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis

    S. Hani Najafi-Shoushtari;Fjoralba Kristo;Yingxia Li;Toshi Shioda

  • Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy

    Francesco Loffredo;Matthew L. Steinhauser;Steven M. Jay;Joseph Gannon

  • Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab

    Heloisa Sawaya;Igal A. Sebag;Juan Carlos Plana;James L. Januzzi

  • Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.

    Heloisa Sawaya;Igal A. Sebag;Juan Carlos Plana;James Louis Januzzi

  • Sildenafil Improves Exercise Capacity and Quality of Life in Patients with Systolic Heart Failure and Secondary Pulmonary Hypertension

    Gregory D. Lewis;Ravi Shah;Khurram Shahzad;Janice M. Camuso

  • Metabolite Profiling and Cardiovascular Event Risk A Prospective Study of 3 Population-Based Cohorts

    Peter Würtz;Aki S Havulinna;Pasi Soininen;Tuulia Tynkkynen

  • Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans

    Eugene P. Rhee;Susan Cheng;Susan Cheng;Martin G. Larson;Geoffrey A. Walford

  • Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development

    Jared R Mayers;Chen Wu;Chen Wu;Clary B Clish;Peter Kraft

  • Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans

    Susan Cheng;Eugene P. Rhee;Martin G. Larson;Gregory D. Lewis

  • β-Aminoisobutyric Acid Induces Browning of White Fat and Hepatic β-Oxidation and Is Inversely Correlated with Cardiometabolic Risk Factors

    Lee D. Roberts;Pontus Boström;Pontus Boström;John F. O’Sullivan;Robert T. Schinzel

  • Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells

    Christoph Patsch;Ludivine Challet-Meylan;Eva C. Thoma;Eduard Urich

  • Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia

    Marc S. Sabatine;Emerson Liu;David A. Morrow;Eric Heller

  • Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab.

    Bonnie Ky;Mary Putt;Heloisa Sawaya;Benjamin French

  • UNIT 30.2 Targeted Metabolomics

    Lee D. Roberts;Amanda L. Souza;Robert E. Gerszten;Robert E. Gerszten;Clary B. Clish

  • Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program

    Daniel Taliun;Daniel N. Harris;Michael D. Kessler;Jedidiah Carlson;Jedidiah Carlson

  • Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment.

    Andrew M Tager;Shannon K Bromley;Benjamin D Medoff;Sabina A Islam

Frequent Co-Authors

Thomas J. Wang
Thomas J. Wang Vanderbilt University
Ramachandran S. Vasan
Ramachandran S. Vasan The University of Texas Health Science Center at San Antonio
Clary B. Clish
Clary B. Clish Broad Institute
Qiong Yang
Qiong Yang Boston University
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Susan Cheng
Susan Cheng Cedars-Sinai Medical Center
Christopher J. O'Donnell
Christopher J. O'Donnell Harvard Medical School
Jose C. Florez
Jose C. Florez Harvard University
Anthony Rosenzweig
Anthony Rosenzweig Harvard University
Randall T. Peterson
Randall T. Peterson University of Utah

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine offers many opportunities beyond traditional doctor roles. Today, online education has made healthcare careers much more accessible, with flexible options that suit various interests and backgrounds.

For example, those interested in behind-the-scenes roles may want to look into the average cost of medical billing and coding program to see how affordable these entry-level certifications can be. If you’re considering providing direct patient care, online nursing programs are a popular option. Check out nursing school online to find flexible pathways to registered nursing credentials.

For those who wish to advance their nursing career, becoming a nurse practitioner can be a rewarding route. Review nurse practitioner programs to learn about affordable, online options that offer leadership and specialized clinical roles. If research or academic leadership is your goal, explore online phd programs nursing for advanced degrees that open doors to teaching and administration.

These online programs offer flexibility, lower costs, and a range of healthcare career pathways that can be tailored to your passion and professional goals.

Best Scientists Citing Robert E. Gerszten

Trending Scientists

Recently Published Articles